Poxel S.A. (EPA:POXEL)
0.2000
+0.0020 (1.01%)
Jul 14, 2026, 9:15 AM CET
Poxel Market Cap
Poxel has a market cap or net worth of €10.64 million as of July 13, 2026. Its market cap has decreased by -65.04% in one year.
Market Cap
10.64M
Enterprise Value
70.59M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.20
Market Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 193.09M to 10.64M, a decrease of -94.49%. That is a compound annual growth rate of -22.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 10.64M | -15.38% |
| Dec 31, 2025 | 12.57M | 69.26% |
| Dec 31, 2024 | 7.43M | -61.80% |
| Dec 29, 2023 | 19.45M | -28.41% |
| Dec 30, 2022 | 27.16M | -80.72% |
| Dec 31, 2021 | 140.90M | -22.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 33.93M |
| Advicenne | 25.75M |
| genOway Société anonyme | 22.13M |
| GenSight Biologics | 19.27M |
| Aelis Farma | 14.28M |
| NFL Biosciences | 10.77M |
| Aton | 8.78M |
| Plant Advanced Technologies | 7.19M |